Joanna Sadowska, PhD, EMBA

Joanna Sadowska, PhD, EMBA

Boston, Massachusetts, United States
38K followers 500+ connections

About

Life sciences leader who has worked, lived or studied across Europe, the US and…

Services

Activity

Join now to see all activity

Experience

  • Be Biopharma Graphic
  • -

    Boston, Massachusetts, United States

  • -

    Pennsylvania, United States

  • -

    Dublin, County Dublin, Ireland

  • -

  • -

    County Dublin, Ireland

  • -

    Barcelona Area, Spain

  • -

    Barcelona Area, Spain

  • -

    Brisbane, Australia

  • -

    Uppsala, Sweden

  • -

    Cracow, Lesser Poland District, Poland

Education

Licenses & Certifications

Publications

  • Bone biomaterials for overcoming antimicrobial resistance: Advances in non-antibiotic antimicrobial approaches for regeneration of infected osseous tissue

    Materials Today

    Eliminating bacterial infection and simultaneously providing a bioactive environment for bone growth during treatment of severe osteomyelitis is one of the greatest global challenges of modern orthopaedics. Additionally, antibiotic resistance has been deemed a major threat to public health resulting in 700,000 deaths globally per year. Therefore, the development of multifunctional non-antibiotic antimicrobial biomaterials that could locally fight highly resistant bacteria while providing a…

    Eliminating bacterial infection and simultaneously providing a bioactive environment for bone growth during treatment of severe osteomyelitis is one of the greatest global challenges of modern orthopaedics. Additionally, antibiotic resistance has been deemed a major threat to public health resulting in 700,000 deaths globally per year. Therefore, the development of multifunctional non-antibiotic antimicrobial biomaterials that could locally fight highly resistant bacteria while providing a template for osseous tissue ingrowth would be a major breakthrough. Current research focuses on a myriad of technologies to create non-antibiotic antimicrobial pro-osteogenic biomaterials, ranging from the inherently antimicrobial, based on the effects of chemistry or topography, to the application of antimicrobial metal ions and oxides, polymers, or peptides, as well as the potential of utilising biofilm degrading enzymes, quorum sensing drugs, and bacteriophages. In this review, we have provided an overview of the currently available treatments for osteomyelitis with a special focus on novel, non-antibiotic based solutions currently being developed and their antimicrobial mechanisms. Finally, we will present discussion on future directions in the clinical translation of alternative biomaterial-based approaches to treat osteomyelitis.

    Other authors
    See publication
  • Development of collagen-poly (caprolactone)-based core-shell scaffolds supplemented with proteoglycans and glycosaminoglycans for ligament repair

    Materials Science and Engineering: C

    Core-shell scaffolds offer a promising regenerative solution to debilitating injuries to anterior cruciate ligament (ACL) thanks to a unique biphasic structure. Nevertheless, current core-shell designs are impaired by an imbalance between permeability, biochemical and mechanical cues. This study aimed to address this issue by creating a porous core-shell construct which favors cell infiltration and matrix production, while providing mechanical stability at the site of injury. The developed…

    Core-shell scaffolds offer a promising regenerative solution to debilitating injuries to anterior cruciate ligament (ACL) thanks to a unique biphasic structure. Nevertheless, current core-shell designs are impaired by an imbalance between permeability, biochemical and mechanical cues. This study aimed to address this issue by creating a porous core-shell construct which favors cell infiltration and matrix production, while providing mechanical stability at the site of injury. The developed core-shell scaffold combines an outer shell of electrospun poly(caprolactone) fibers with a freeze-dried core of type I collagen doped with proteoglycans (biglycan, decorin) or glycosaminoglycans (chondroitin sulphate, dermatan sulphate). The aligned fibrous shell achieved an elastic modulus akin of the human ACL, while the porous collagen core is permeable to human mesenchymal stem cell (hMSC). Doping of the core with the aforementioned biomolecules led to structural and mechanical changes in the pore network. Assessment of cellular metabolic activity and scaffold contraction shows that hMSCs actively remodel the matrix at different degrees, depending on the core's doping formulation. Additionally, immunohistochemical staining and mRNA transcript levels show that the collagen-chondroitin sulphate formulation has the highest matrix production activity, while the collagen-decorin formulation featured a matrix production profile more characteristic of the undamaged tissue. Together, this demonstrates that scaffold doping with target biomolecules leads to distinct levels of cell-mediated matrix remodeling. Overall, this work resulted in the development of a versatile and robust platform with a combination of mechanical and biochemical features that have a significant potential in promoting the repair process of ACL tissue.

    Other authors
    See publication
  • Inflammation and biomaterials: role of the immune response in bone regeneration by inorganic scaffolds

    Journal of Materials Chemistry B

    The regulatory role of the immune system in maintaining bone homeostasis and restoring its functionality, when disturbed due to trauma or injury, has become evident in recent years. The polarization of macrophages, one of the main constituents of the immune system, into the pro-inflammatory or anti-inflammatory phenotype has great repercussions for cellular crosstalk and the subsequent processes needed for proper bone regeneration such as angiogenesis and osteogenesis. In certain scenarios, the…

    The regulatory role of the immune system in maintaining bone homeostasis and restoring its functionality, when disturbed due to trauma or injury, has become evident in recent years. The polarization of macrophages, one of the main constituents of the immune system, into the pro-inflammatory or anti-inflammatory phenotype has great repercussions for cellular crosstalk and the subsequent processes needed for proper bone regeneration such as angiogenesis and osteogenesis. In certain scenarios, the damaged osseous tissue requires the placement of synthetic bone grafts to facilitate the healing process. Inorganic biomaterials such as bioceramics or bioactive glasses are the most widely used due to their resemblance to the mineral phase of bone and superior osteogenic properties. The immune response of the host to the inorganic biomaterial, which is of an exogenous nature, might determine its fate, leading either to active bone regeneration or its failure. Therefore, various strategies have been employed, like the modification of structural/chemical features or the incorporation of bioactive molecules, to tune the interplay with the immune cells. Understanding how these particular modifications impact the polarization of macrophages and further osteogenic and osteoclastogenic events is of great interest in view of designing a new generation of osteoimmunomodulatory materials that support the regeneration of osseous tissue during all stages of bone healing.

    Other authors
    See publication
  • The effect of biomimetic calcium deficient hydroxyapatite and sintered β-tricalcium phosphate on osteoimmune reaction and osteogenesis

    Acta Biomaterialia

    Biomaterial implantation triggers inflammatory reactions. Understanding the effect of physicochemical features of biomaterials on the release of inflammatory cytokines from immune cells would be of great interest in view of designing bone graft materials to enhance the healing of bone defects. The present work investigated the interactions of two chemically and texturally different calcium phosphate (CaPs) substrates with macrophages, one of the main innate immune cells, and its further impact…

    Biomaterial implantation triggers inflammatory reactions. Understanding the effect of physicochemical features of biomaterials on the release of inflammatory cytokines from immune cells would be of great interest in view of designing bone graft materials to enhance the healing of bone defects. The present work investigated the interactions of two chemically and texturally different calcium phosphate (CaPs) substrates with macrophages, one of the main innate immune cells, and its further impact on osteogenic differentiation of bone forming cells. The behaviour of macrophages seeded on biomimetic calcium deficient hydroxyapatite (CDHA) and sintered β-tricalcium phosphate (β-TCP) was assessed in terms of the release of inflammatory cytokines and osteoclastogenic factors. The osteogenic differentiation of bone progenitor cells (bone marrow stromal cells (BMSCs) and osteoblastic cell line (SaOS-2)) were subsequently studied by incubating with the conditioned medium induced by macrophage-CaPs interaction in order to reveal the effect of immune cell reaction to CaPs on osteogenic differentiation. It was found that the incubation of macrophages with CaPs substrates caused a decrease of pro-inflammatory cytokines, more pronounced for β-TCP compared with CDHA showing significantly decreased IL-6, TNF-a, and iNOS. However, the macrophage-CDHA interaction resulted in a more favourable environment for osteogenic differentiation of osteoblasts with more collagen type I production and osteogenic genes (Runx2, BSP) expression, suggesting that osteogenic differentiation of bone cells is not only determined by the nature of biomaterials, but also significantly influenced by the inflammatory environment generated by the interaction of immune cells and biomaterials.

    Other authors
    See publication
  • The impact of biomimicry in the design of osteoinductive bone substitutes: nanoscale matters

    ACS Applied Materials & Interfaces

    Bone apatite consists of carbonated calcium-deficient hydroxyapatite (CDHA) nanocrystals. Biomimetic routes allow fabricating synthetic bone grafts that mimic biological apatite. In this work, we explored the role of two distinctive features of biomimetic apatites, namely, nanocrystal morphology (plate vs needle-like crystals) and carbonate content, on the bone regeneration potential of CDHA scaffolds in an in vivo canine model. Both ectopic bone formation and scaffold degradation were…

    Bone apatite consists of carbonated calcium-deficient hydroxyapatite (CDHA) nanocrystals. Biomimetic routes allow fabricating synthetic bone grafts that mimic biological apatite. In this work, we explored the role of two distinctive features of biomimetic apatites, namely, nanocrystal morphology (plate vs needle-like crystals) and carbonate content, on the bone regeneration potential of CDHA scaffolds in an in vivo canine model. Both ectopic bone formation and scaffold degradation were drastically affected by the nanocrystal morphology after intramuscular implantation. Fine-CDHA foams with needle-like nanocrystals, comparable in size to bone mineral, showed a markedly higher osteoinductive potential and a superior degradation than chemically identical coarse-CDHA foams with larger plate-shaped crystals. These findings correlated well with the superior bone-healing capacity showed by the fine-CDHA scaffolds when implanted intraosseously. Moreover, carbonate doping of CDHA, which resulted in small plate-shaped nanocrystals, accelerated both the intrinsic osteoinduction and the bone healing capacity, and significantly increased the cell-mediated resorption. These results suggest that tuning the chemical composition and the nanostructural features may allow the material to enter the physiological bone remodeling cycle, promoting a tight synchronization between scaffold degradation and bone formation.

    Other authors
    See publication
  • The Influence of Physicochemical Properties of Biomimetic Hydroxyapatite on the In Vitro Behavior of Endothelial Progenitor Cells and Their Interaction with Mesenchymal Stem Cells

    Advanced Healthcare Materials

    Calcium phosphate (CaP) substrates are successfully used as bone grafts due to their osteogenic properties. However, the influence of the physicochemical features of CaPs in angiogenesis is frequently neglected despite it being a crucial process for bone regeneration. The present work focuses on analyzing the effects of textural parameters of biomimetic calcium deficient hydroxyapatite (CDHA) and sintered beta-tricalcium phosphate (β-TCP), such as specific surface area, surface roughness, and…

    Calcium phosphate (CaP) substrates are successfully used as bone grafts due to their osteogenic properties. However, the influence of the physicochemical features of CaPs in angiogenesis is frequently neglected despite it being a crucial process for bone regeneration. The present work focuses on analyzing the effects of textural parameters of biomimetic calcium deficient hydroxyapatite (CDHA) and sintered beta-tricalcium phosphate (β-TCP), such as specific surface area, surface roughness, and microstructure, on the behavior of rat endothelial progenitor cells (rEPCs) and their crosstalk with rat mesenchymal stem cells (rMSCs). The higher reactivity of CDHA results in low proliferation rates in monocultured and cocultured systems. This effect is especially pronounced for rMSCs alone, and for CDHA with a fine microstructure. In terms of angiogenic and osteogenic gene expressions, the upregulation of particular genes is especially enhanced for needle-like CDHA compared to plate-like CDHA and β-TCP, suggesting the importance not only of the chemistry of the substrate, but also of its textural features. Moreover, the coculture of rEPCs and rMSCs on needle-like CDHA results in early upregulation of osteogenic modulator, i.e., protein deglycase 1 might be a possible cause of overexpression of osteogenic-related genes on the same substrate.

    Other authors
    See publication
  • Effect of nano-structural properties of biomimetic hydroxyapatite on osteoimmunomodulation

    Biomaterials (2018) 181: 318-332

    Immune cells are sensitive to the microstructural and textural properties of materials. Tuning the structural features of synthetic bone grafts could be a valuable strategy to regulate the specific response of the immune system, which in turn modulates the activity of bone cells. The aim of this study was to analyse the effect of the structural characteristics of biomimetic calcium deficient hydroxyapatite (CDHA) on the innate immune response of macrophages and the subsequent impact on…

    Immune cells are sensitive to the microstructural and textural properties of materials. Tuning the structural features of synthetic bone grafts could be a valuable strategy to regulate the specific response of the immune system, which in turn modulates the activity of bone cells. The aim of this study was to analyse the effect of the structural characteristics of biomimetic calcium deficient hydroxyapatite (CDHA) on the innate immune response of macrophages and the subsequent impact on osteogenesis and osteoclastogenesis. Murine RAW 264.7 cells were cultured, under standard and inflammatory conditions, on chemically identical CDHA substrates that varied in microstructure and porosity. The impact on osteogenesis was evaluated by incubating osteoblastic cells (SaOS-2) with RAW-CDHA conditioned extracts. The results showed that macrophages were sensitive to different textural and structural properties of CDHA. Under standard conditions, the impact of inflammatory cytokine production by RAW cells cultured on CDHA played a significant role in the degradation of substrates, suggesting the impact of resorptive behaviour of RAW cells on biomimetic surfaces. Osteoblast differentiation was stimulated by the conditioned media collected from RAW cells cultured on needle-like nanostructured CDHA. The results demonstrated that needle-like nanostructured CDHA was able to generate a favourable osteoimmune environment to regulate osteoblast differentiation and osteogenesis. Under inflammatory conditions, the incubation of RAW cells with less porous CDHA resulted in a decreased gene expression and release of pro-inflammatory cytokines.

    Other authors
    See publication
  • In vitro response of mesenchymal stem cells to biomimetic hydroxyapatite substrates: A new strategy to assess the effect of ion exchange

    Acta Biomaterialia (2018) 76:319-332

    Biomaterials can interact with cells directly, that is, by direct contact of the cells with the material surface, or indirectly, through soluble species that can be released to or uptaken from the surrounding fluids. However, it is difficult to characterise the relevance of this fluid-mediated interaction separately from the topography and composition of the substrate, because they are coupled variables. These fluid-mediated interactions are amplified in the case of highly reactive calcium…

    Biomaterials can interact with cells directly, that is, by direct contact of the cells with the material surface, or indirectly, through soluble species that can be released to or uptaken from the surrounding fluids. However, it is difficult to characterise the relevance of this fluid-mediated interaction separately from the topography and composition of the substrate, because they are coupled variables. These fluid-mediated interactions are amplified in the case of highly reactive calcium phosphates (CaPs) such as biomimetic calcium deficient hydroxyapatite (CDHA), particularly in static in vitro cultures. The present work proposes a strategy to decouple the effect of ion exchange from topographical features by adjusting the volume ratio between the cell culture medium and biomaterial (VCM/VB). Increasing this ratio allowed mitigating the drastic ionic exchanges associated to the compositional changes experienced by the material exposed to the cell culture medium. This strategy was validated using rat mesenchymal stem cells (rMSCs) cultured on CDHA and beta-tricalcium phosphate (β-TCP) discs using different VCM/VB ratios. Whereas in the case of β-TCP the cell response was not affected by this ratio, a significant effect on cell adhesion and proliferation was found for the more reactive CDHA. The ionic exchange, produced by CDHA at low VCM/VB, altered cell adhesion due to the reduced number of focal adhesions, caused cell shrinkage and further rMCSs apoptosis. This was mitigated when using a high VCM/VB, which attenuated the changes of calcium and phosphate concentrations in the cell culture medium, resulting in rMSCs spreading and a viability over time. Moreover, rMSCs showed an earlier expression of osteogenic genes on CDHA compared to sintered β-TCP when extracellular calcium fluctuations were reduced.

    Other authors
    See publication
  • Osteoinduction by Foamed and 3D-Printed Calcium Phosphate Scaffolds: Effect of Nanostructure and Pore Architecture

    ACS Applied Materials & Interfaces (2017) 9: 41722-41736

    Some biomaterials are osteoinductive, that is, they are able to trigger the osteogenic process by inducing the differentiation of mesenchymal stem cells to the osteogenic lineage. Although the underlying mechanism is still unclear, microporosity and specific surface area (SSA) have been identified as critical factors in material-associated osteoinduction. However, only sintered ceramics, which have a limited range of porosities and SSA, have been analyzed so far. In this work, we were able to…

    Some biomaterials are osteoinductive, that is, they are able to trigger the osteogenic process by inducing the differentiation of mesenchymal stem cells to the osteogenic lineage. Although the underlying mechanism is still unclear, microporosity and specific surface area (SSA) have been identified as critical factors in material-associated osteoinduction. However, only sintered ceramics, which have a limited range of porosities and SSA, have been analyzed so far. In this work, we were able to extend these ranges to the nanoscale, through the foaming and 3D-printing of biomimetic calcium phosphates, thereby obtaining scaffolds with controlled micro- and nanoporosity and with tailored macropore architectures. Calcium-deficient hydroxyapatite (CDHA) scaffolds were evaluated after 6 and 12 weeks in an ectopic-implantation canine model and compared with two sintered ceramics, biphasic calcium phosphate and β-tricalcium phosphate. Only foams with spherical, concave macropores and not 3D-printed scaffolds with convex, prismatic macropores induced significant ectopic bone formation. Among them, biomimetic nanostructured CDHA produced the highest incidence of ectopic bone and accelerated bone formation when compared with conventional microstructured sintered calcium phosphates with the same macropore architecture. Moreover, they exhibited different bone formation patterns; in CDHA foams, the new ectopic bone progressively replaced the scaffold, whereas in sintered biphasic calcium phosphate scaffolds, bone was deposited on the surface of the material, progressively filling the pore space. In conclusion, this study demonstrates that the high reactivity of nanostructured biomimetic CDHA combined with a spherical, concave macroporosity allows the pushing of the osteoinduction potential beyond the limits of microstructured calcium phosphate ceramics.

    Other authors
    See publication
  • Biomimetic Versus Sintered Calcium Phosphates: The In Vitro Behavior of Osteoblasts and Mesenchymal Stem Cells

    Tissue Engineering: Part A 23(23-24):1297-1309

    The fabrication of calcium phosphates using biomimetic routes, namely, precipitation processes at body temperature, results in distinct features compared to conventional sintered calcium phosphate ceramics, such as a high specific surface area (SSA) and micro- or nanometric crystal size. The aim of this article is to analyze the effects of these parameters on cell response, focusing on two bone cell types: rat mesenchymal stem cells (rMSCs) and human osteoblastic cells (SaOS-2). Biomimetic…

    The fabrication of calcium phosphates using biomimetic routes, namely, precipitation processes at body temperature, results in distinct features compared to conventional sintered calcium phosphate ceramics, such as a high specific surface area (SSA) and micro- or nanometric crystal size. The aim of this article is to analyze the effects of these parameters on cell response, focusing on two bone cell types: rat mesenchymal stem cells (rMSCs) and human osteoblastic cells (SaOS-2). Biomimetic calcium-deficient hydroxyapatite (CDHA) was obtained by a low temperature setting reaction, and α-tricalcium phosphate (α-TCP) and β-tricalcium phosphate were subsequently obtained by sintering CDHA either at 1400°C or 1100°C. Sintered stoichiometric hydroxyapatite (HA) was also prepared using ceramic routes. The materials were characterized in terms of SSA, skeletal density, porosity, and pore size distribution. SaOS-2 cells and rMSCs were seeded either directly on the surfaces of the materials or on glass coverslips subsequently placed on top of the materials to expose the cells to the CaP-induced ionic changes in the medium, while avoiding any topography-related effects. CDHA produced higher ionic fluctuations in both cell culture media than sintered ceramics, with a strong decrease of calcium and a release of phosphate. Indirect contact cell cultures revealed that both cell types were sensitive to these ionic modifications, resulting in a decrease in proliferation rate, more marked for CDHA, this effect being more pronounced for rMSCs. In direct contact cultures, good cell adhesion was found on all materials, but, while cells were able to proliferate on the sintered calcium phosphates, cell number was significantly reduced with time on biomimetic CDHA, which was associated to a higher percentage of apoptotic cells. Direct contact of the cells with biomimetic CDHA resulted also in a higher ALP activity for both cell types compared to sintered CaPs.

    Other authors
    See publication
Join now to see all publications

Courses

  • Applied Economics & Managerial Decision Making

    -

  • Business Insights through Data

    -

  • Business Intelligence

    -

  • Crisis Management, Mitigation & Response

    -

  • Data Management

    -

  • Emerging Tech for Executives

    -

  • Finance 3.0 for Executives

    -

  • Financial Management & Decision Making

    -

  • Financial Statement Analysis

    -

  • Financial Statement Analysis

    -

  • Global Business Strategy

    -

  • Global Operations

    -

  • International Negotiations

    -

  • Marketing Strategy

    -

  • Operations Strategy

    -

Projects

  • Gene-activated scaffolds for the treatment of Epidermolysis Bullosa

    Epidermolysis Bullosa (EB) is a rare genetic skin condition affecting about 1 in every 30,000 babies worldwide and 1 in 18,000 children born in Ireland. In patients with EB, defective genes make the skin extremely fragile, causing it to tear or blister from even the slightest touch. EB is also associated with many other health complications.

    In this project, we propose a unique approach combining gene therapy to fix the defective gene with tissue engineering to create a special patch…

    Epidermolysis Bullosa (EB) is a rare genetic skin condition affecting about 1 in every 30,000 babies worldwide and 1 in 18,000 children born in Ireland. In patients with EB, defective genes make the skin extremely fragile, causing it to tear or blister from even the slightest touch. EB is also associated with many other health complications.

    In this project, we propose a unique approach combining gene therapy to fix the defective gene with tissue engineering to create a special patch. This patch will help heal EB skin tears or wounds. Our idea is to develop a gene-activated patch as a ready-to-use treatment for EB wounds, which will act as a protective dressing and potentially fight bacteria for external wounds and blisters.

    Typically, gene therapy uses viruses to deliver genes to cells, which can raise safety and regulatory concerns. Instead, we will create a "gene-activated scaffold" or “patch” containing tiny particles with the corrected forms of the defective genes. These particles will safely and efficiently deliver the corrected genes to the target cells. After obtaining promising preliminary data from this project using two- and three-dimensional cells, we will apply for funding for a larger grant to test these patches in living organisms.

    Our ultimate goal is for the gene-activated patch to be placed into an EB skin wound, where the patient's own cells will move into the patch, pick up the tiny particles, and start using the corrected gene to improve healing.

    Reducing wound severity, and risk of infection, and speeding up wound healing are top priorities for patients with EB and their caregivers. Our research aims to not only reduce wounds but also provide antimicrobial properties to kill bacteria and prevent infections. Thus, our ready-to-use gene-activated scaffolds could promote successful wound healing in EB patients while minimising infection. This improved wound healing and reduced infection risk may also help prevent other complications.

  • Development of novel gene-activated scaffolds delivering mRNA encoding bone morphogenetic protein-2 and bone morphogenetic protein-7 for bone regeneration

    The main goal of the present project is to use the scaffolds as a platform for the local delivery and co-delivery of cmBMP-2 and cmBMP-2 and evaluate their capacity to heal bone. The development of Pfizer and Moderna vaccines for COVID-19 introduced the mRNA to clinical practice. With this research project, we want to introduce the cmRNA technology to regenerative medicine applications providing outcomes which will have a transformative effect on the field of gene therapy with a potential for a…

    The main goal of the present project is to use the scaffolds as a platform for the local delivery and co-delivery of cmBMP-2 and cmBMP-2 and evaluate their capacity to heal bone. The development of Pfizer and Moderna vaccines for COVID-19 introduced the mRNA to clinical practice. With this research project, we want to introduce the cmRNA technology to regenerative medicine applications providing outcomes which will have a transformative effect on the field of gene therapy with a potential for a myriad of applications like the treatment of bone fractures and it will improve the quality of life for many patients worldwide.

  • Bioactive scaffolds functionalised for the delivery of genetic cargoes for the healing of complex wounds (WoundActiv)

    The project WoundActiv has been founded by the Higher Education Authority. It is a collaborative project between the Royal College of Surgeons in Ireland, the Queen's University Belfast and industry partner pHion Therapeutics. The project aims to develop a new treatment for healing complex chronic wounds such as those caused by diabetes - leading to diabetic foot ulcers (DFU). The WoundActiv develops a next-generation therapeutic biomaterial scaffold with antimicrobial properties to limit…

    The project WoundActiv has been founded by the Higher Education Authority. It is a collaborative project between the Royal College of Surgeons in Ireland, the Queen's University Belfast and industry partner pHion Therapeutics. The project aims to develop a new treatment for healing complex chronic wounds such as those caused by diabetes - leading to diabetic foot ulcers (DFU). The WoundActiv develops a next-generation therapeutic biomaterial scaffold with antimicrobial properties to limit infections, functionalised with pro-angiogenic and anti-fibrotic nucleic acids, to ensure normal progression through the wound healing pathway and promote efficient skin regeneration.

  • Therapeutical applications of Cold Plasmas: PlasTHER

    The Action PlasTHER has been founded by the European Cooperation in Science and Technology. The consortium gathers over 100 participants from more than 25 countries. This Action is concerned with the medical and biomedical applications of cold atmospheric plasmas. The main aim of the PlasTHER COST Action is to exploit the unprecedented possibilities of atmospheric pressure plasmas in medicine to share, develop and consolidate suitable therapies currently under investigation to make Europe’s…

    The Action PlasTHER has been founded by the European Cooperation in Science and Technology. The consortium gathers over 100 participants from more than 25 countries. This Action is concerned with the medical and biomedical applications of cold atmospheric plasmas. The main aim of the PlasTHER COST Action is to exploit the unprecedented possibilities of atmospheric pressure plasmas in medicine to share, develop and consolidate suitable therapies currently under investigation to make Europe’s science and healthcare world leaders in this field.

    See project
  • Non-viral Delivery of Genetic Cargo on Biomaterial Scaffolds for Bone Regeneration

    The project has been founded by the National Science Foundation- Science Foundation Ireland US-Ireland R&D Partnership Programme. The project involves collaborations with academics (Queen's University Belfast, Dublin City University, University of Massachusetts Amherst) and industry partners (pHion Therapeutics). The goal of the project is to develop a novel materials-based approach for delivering genetic cargo to improve the healing of large bone defects.

  • Gene-Activated AntiMicorbial Biomaterials for Bone regeneration (GAMBBa)

    -

    The project GAMBBa has been founded by the European Commission. The aim of the project is to address the clinical problem of osteomyelitis i.e. bone infection, by eliminating bacterial infection while also regenerating the large volumes of bone lost to the disease. GAMBBa develops biomaterial scaffolds that, for the first time, combines the controlled delivery of osteoanabolic genetic cargo for bone healing with non-antibiotic antimicrobial nanoparticles (a-NPs).

  • Gene-activated scaffolds for repair of osteoporosis-associated fractures of long bones

    -

    The project has been founded by the Orthoregenerartion Network Foundation. The goal of this project is to develop an innovative scaffold with immense potential to generate new healthy bone in
    patients suffering from osteoporosis. The project delivers nucleic acids, using non-viral vectors, to target the reduced healing capacity of osteoporotic fractures repairing osteoporotic bone.

  • Advanced scaffold-based therapeutics for regeneration of large volume, vascularised bone defects

    -

    The project has been founded by the Health Research Board. The project develops an advanced therapeutic capable of promoting both blood vessel ingrowth and bone formation for the repair of large bone defects. The technology consists of a gene-activated scaffold capable of controlled delivery of both osteogenic and angiogenic plasmid DNA (pDNA) and microRNAs (miRs).

  • BIOPLASMA – Innovation in advanced coatings for biomedical applications obtained by means of vacuum plasma assisted deposition techniques

    -

    The project has been founded by the Spanish Ministry of Science, Innovation and Universities and the European Union. The BIOPLASMA project develops advanced and innovative coatings for biomedical applications, such as prostheses or implants, with the aim to improve the biological response of these components, eliminating the clinical and surgical complications derived from both chemical and mechanical lack of biocompatibility and biostability. The BIOPLASMA develops coatings with good wear…

    The project has been founded by the Spanish Ministry of Science, Innovation and Universities and the European Union. The BIOPLASMA project develops advanced and innovative coatings for biomedical applications, such as prostheses or implants, with the aim to improve the biological response of these components, eliminating the clinical and surgical complications derived from both chemical and mechanical lack of biocompatibility and biostability. The BIOPLASMA develops coatings with good wear resistance, high hardness and adhesion, a low coefficient of friction and good antibacterial properties.

    See project
  • MAXIBONE: Personalised maxillofacial bone regeneration

    -

    The project has been founded by the European Commission. The consortium gathers 12 partners from 6 European countries including research laboratories, academic hospitals, cell therapy units, SME manufacturing biomaterials and the global leader of dental implants. The European project MAXIBONE aims to create personalized maxillary bone regeneration by using culture-expanded autologous bone marrow stem cells and biomaterials.

    See project
  • Pore4Bone: Biomimetic calcium phosphates: tailoring porosity from the nano- to the macroscale for osteoinduction, drug delivery and bone tissue engineering

    -

    The project has been founded by the Spanis Ministry of Economy and Competitiveness. The project develops calcium phosphate materials for bone regeneration optimising their physiochemical properties to induce favourable cell response.

Honors & Awards

  • 2023 L'Oréal - UNESCO FOR WOMEN IN SCIENCE UK 7 IRELAND RISING TALENT AWARDS

    L'Oréal - UNESCO

  • 2023 New Investigator Recognition Awards

    The Orthopeadic Research Society

  • The Royal Irish Academy Charlemont Grants

    The Royal Irish Academy

    The research grant supports interinstitutional collaboration and two-way transfer of knowledge between the Royal College of Surgeons in Ireland and Maastricht University.

  • SFI Industry Fellowship

    Science Foundation Ireland

    The research grant supports the collaboration with the US-based pharmaceutical company Alnylam to evalaue late stage development of gene therapy for the treatment of polyneuropathies caused by hATTA

  • The Enterprise Ireland H2020 Co-ordinator Proposal Preparation Support Scheme

    The Enterprise Ireland

    EI Horizon Europe Coordinator-Support covers activities associated with the preparation of an application to the European Commission by the researchers based in Ireland, €16,000

  • COST Action PlasTHER Therapeutical applications of Cold Plasmas

    The European Cooperation in Science and Technology

    The grant 'COST Actions' aims to provide networking opportunities for researchers and innovators in order to strengthen Europe’s capacity to address scientific, technological and societal challenges. The Action PlasTHER gathers over 100 researchers from more than 25 countries who investigate the medicinal and biological potential of plasmas, €125,000/year

  • ON Kick-Starter Grant bone

    The Orthoregenerartion Network Foundation

    A research grant, sponsored by the Orthoregenerartion Network Foundation, to support the research that focuses on innovative approaches in regenerative orthopaedics or that answers an important open question in that field, CHF10,000

  • Marie Sklodowska-Curie Individual Postdoctoral Fellowship

    The European Comission

    The Marie Sklodowska-Curie Postdoctoral Fellowships are the most competitive and prestigious fellowships for excellent early career researchers undertaking international mobility either to or between the EU Member States or Horizon Europe Associated as to non-associated Third Countries.

    The goal of MSCA Postdoctoral Fellowships is to enhance the creative and innovative potential of researchers holding a PhD who wish to acquire new skills through advanced training and international…

    The Marie Sklodowska-Curie Postdoctoral Fellowships are the most competitive and prestigious fellowships for excellent early career researchers undertaking international mobility either to or between the EU Member States or Horizon Europe Associated as to non-associated Third Countries.

    The goal of MSCA Postdoctoral Fellowships is to enhance the creative and innovative potential of researchers holding a PhD who wish to acquire new skills through advanced training and international, interdisciplinary and inter-sectoral mobility.

    My proposal 'GAMBBa: Gene-Activated AntiMicorbial Biomaterials for Bone regeneration' received the evaluation of 100% scoring 1st over the 951 proposals in Information Science and Engineering panel, €184,590.72

  • Julia Polak European Doctorate Award by European Society for Biomaterials

    The European Society for Biomaterials

    The award, by the council of the European Society for Biomaterials, recognises a high-quality thesis in the field of biomaterials, tissue engineering and regenerative medicine.

  • Winner of the UPC institutional final of the contest “Thesis in 4 minutes”

    Universitat Politècnica de Catalunya (UPC-BarcelonaTECH), Barcelona, Spain

    The competition challenges doctoral students in any scientific discipline to explain their research to a non-specialist audience and prove their excellent communication skills.

  • Mobility grant

    The Swedish Foundation for International Cooperation in Research and Higher Education

    The grant promotes knowledge and competence development within internationalisation and invests in internationalisation projects proposed by researchers, educators and leadership between Swedish and foreign universities, €2,000

  • Mobility grant

    The Spanish Ministry of Economics and Competitiveness

    This higher education mobility action, awarded by the Spanish Ministry of Economics and Competitiveness, supports the mobility of higher education students from Spanish universities to carry out research abroad at a higher education institution or a research institute, €3,600

  • Mobility grant Erasmus + Teaching Mobility 2015/2016

    The European Commission

    This higher education mobility action supports the teaching missions to be carried out abroad at a partner higher education institution, €550

  • PhD Individual Scholarship by Spanish Ministry of Economics and Competitiveness

    Spanish Ministry of Economics and Competitiveness

    A competitive PhD scholarship awarded by the Spanish Ministry of Economics and Competitiveness under the programme “Ayudas para contratos predoctorales para la formación de doctores 2013”, €65,688

  • Mobility grant Erasmus

    The European Comission

    This higher education mobility action supports the physical and blended mobility of higher education students in any field to study abroad at a partner higher education institution or carry out a traineeship in an enterprise, a research institute, a laboratory, an organisation or any other relevant workplace abroad, €3,500

Languages

  • English

    Full professional proficiency

  • Spanish

    Full professional proficiency

  • Polish

    Native or bilingual proficiency

  • Catalan

    Limited working proficiency

  • French

    Elementary proficiency

Recommendations received

More activity by Joanna

View Joanna’s full profile

  • See who you know in common
  • Get introduced
  • Contact Joanna directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses